BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19161427)

  • 1. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation.
    Maynard CL; Weaver CT
    Immunol Rev; 2008 Dec; 226():219-33. PubMed ID: 19161427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory lymphocytes and intestinal inflammation.
    Izcue A; Coombes JL; Powrie F
    Annu Rev Immunol; 2009; 27():313-38. PubMed ID: 19302043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of regulatory T cell lineage commitment and maintenance.
    Josefowicz SZ; Rudensky A
    Immunity; 2009 May; 30(5):616-25. PubMed ID: 19464984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasticity of CD4+ T cell lineage differentiation.
    Zhou L; Chong MM; Littman DR
    Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mucosal T lymphocytes in regulating intestinal inflammation.
    Uhlig HH; Powrie F
    Springer Semin Immunopathol; 2005 Sep; 27(2):167-80. PubMed ID: 15959782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of regulatory T cell development.
    Chatila T
    J Clin Immunol; 2008 Nov; 28(6):625-30. PubMed ID: 18763025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells in the control of host-microorganism interactions (*).
    Belkaid Y; Tarbell K
    Annu Rev Immunol; 2009; 27():551-89. PubMed ID: 19302048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Th17/Treg imbalance in patients with acute coronary syndrome.
    Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
    Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.
    de Araújo FF; Corrêa-Oliveira R; Rocha MO; Chaves AT; Fiuza JA; Fares RC; Ferreira KS; Nunes MC; Keesen TS; Damasio MP; Teixeira-Carvalho A; Gomes JA
    Immunobiology; 2012 Aug; 217(8):768-77. PubMed ID: 22672991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology. The gut's Clostridium cocktail.
    Barnes MJ; Powrie F
    Science; 2011 Jan; 331(6015):289-90. PubMed ID: 21252334
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of
    Landuyt AE; Klocke BJ; Colvin TB; Schoeb TR; Maynard CL
    J Immunol; 2019 Feb; 202(4):1039-1044. PubMed ID: 30642977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between effector Th17 and regulatory T cells.
    Awasthi A; Murugaiyan G; Kuchroo VK
    J Clin Immunol; 2008 Nov; 28(6):660-70. PubMed ID: 18810613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation.
    Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
    Int Immunopharmacol; 2017 Aug; 49():95-101. PubMed ID: 28558303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV attenuates allergic inflammation by regulation Th1/Th2 cytokine and enhancement CD4(+)CD25(+)Foxp3 T cells in ovalbumin-induced asthma.
    Huang X; Tang L; Wang F; Song G
    Immunobiology; 2014 Jul; 219(7):565-71. PubMed ID: 24731407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.